FTC sues AndroGel drugmakers for unlawfully keeping a generic version off the market
MLex Summary: The US Federal Trade Commission filed a complaint charging AbbVie, Abbott Laboratories, Unimed Pharmaceuticals, Besins Healthcare, and Teva Pharmaceuticals for unlawfully attempting to keep generic versions of the testosterone replacement...To view the full article, register now.
Already a subscriber? Click here to view full article